Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.
about
Milnacipran for pain in fibromyalgia in adultsMilnacipran for neuropathic pain and fibromyalgia in adultsSerotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndromeLow-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.Combining opioid and adrenergic mechanisms for chronic pain.An update on pharmacotherapy for the treatment of fibromyalgia.Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial.The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study.Beyond pain in fibromyalgia: insights into the symptom of fatigue.Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgiaThe role of antipsychotics in the management of fibromyalgia.Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials.Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study
P2860
Q24186461-59C9C88A-2344-4020-A283-2637F2D4669FQ24201093-AB8B14CC-CBB5-4722-A70D-542177B7A5DAQ24201799-5063F7E0-AD2B-492A-A5D7-FA1A902E006DQ34035333-00AC6A0E-68FE-4600-B290-FA4029FBD270Q34434307-E8A2599C-7778-4C4B-8FBB-A5447D0E791CQ34477510-8EC17538-7822-41EB-ADAE-FF46D17DF547Q35368392-088DF794-97DE-4786-8C21-76985F41A963Q36432709-6F67485E-6E8B-4628-8B50-4BAEE234C115Q37690090-E2F009CE-A66D-4C8A-86E1-2707189E3279Q37690358-5C75C94F-A82C-4F22-9567-B95EB8C3FE0DQ37980516-820BF38C-3485-4102-B86D-D242135DD4C4Q38090730-932C7764-B8F8-4A59-8E4C-6FA4E20F6B27Q43075748-8BBEAB0C-DA20-45DC-AC15-4C73090C10B0Q52681690-0858E618-82B6-43F3-A34A-4D17D802C7D0Q57169906-56C9425E-E8A3-4AE4-9793-C43496AD52FC
P2860
Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Longterm therapeutic response ...... udy following a 3-month study.
@en
Longterm therapeutic response ...... udy following a 3-month study.
@nl
type
label
Longterm therapeutic response ...... udy following a 3-month study.
@en
Longterm therapeutic response ...... udy following a 3-month study.
@nl
prefLabel
Longterm therapeutic response ...... udy following a 3-month study.
@en
Longterm therapeutic response ...... udy following a 3-month study.
@nl
P2093
P356
P1476
Longterm therapeutic response ...... udy following a 3-month study.
@en
P2093
Agnes Montagne
Athmane Bouroubi
Multinational Coordinator Study Group
Patrick Cherin
P304
P356
10.3899/JRHEUM.101025
P407
P50
P577
2011-04-01T00:00:00Z